Nathan Hardy

2023

In 2023, Nathan Hardy earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer at Sana Biotechnology.

Compensation breakdown

Non-Equity Incentive Plan$180,123
Option Awards$501,923
Salary$468,921
Stock Awards$30,800
Other$4,000
Total$1,185,767

Hardy received $501.9K in option awards, accounting for 42% of the total pay in 2023.

Hardy also received $180.1K in non-equity incentive plan, $468.9K in salary, $30.8K in stock awards and $4K in other compensation.

Rankings

In 2023, Nathan Hardy's compensation ranked 994th out of 2,790 executives tracked by ExecPay. In other words, Hardy earned more than 64.4% of executives.

ClassificationRankingPercentile
All
994
out of 2,790
64th
Division
Manufacturing
597
out of 1,530
61st
Major group
Chemicals And Allied Products
412
out of 869
53rd
Industry group
Drugs
401
out of 832
52nd
Industry
Biological Products, Except Diagnostic Substances
121
out of 204
41st
Source: SEC filing on April 26, 2024.

Hardy's colleagues

We found two more compensation records of executives who worked with Nathan Hardy at Sana Biotechnology in 2023.

2023

Douglas Williams

Sana Biotechnology

Former Executive Vice President and President, Research and Development

2023

Steven Harr

Sana Biotechnology

Chief Executive Officer

News

You may also like